KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Jazz Pharmaceuticals (JAZZ) Asset Utilization Ratio: 2009-2025

Historic Asset Utilization Ratio for Jazz Pharmaceuticals (JAZZ) over the last 16 years, with Sep 2025 value amounting to 0.37.

  • Jazz Pharmaceuticals' Asset Utilization Ratio rose 10.53% to 0.37 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.37, marking a year-over-year increase of 10.53%. This contributed to the annual value of 0.35 for FY2024, which is 0.79% up from last year.
  • Jazz Pharmaceuticals' Asset Utilization Ratio amounted to 0.37 in Q3 2025, which was up 3.34% from 0.36 recorded in Q2 2025.
  • Jazz Pharmaceuticals' Asset Utilization Ratio's 5-year high stood at 0.37 during Q3 2025, with a 5-year trough of 0.22 in Q3 2021.
  • Over the past 3 years, Jazz Pharmaceuticals' median Asset Utilization Ratio value was 0.34 (recorded in 2023), while the average stood at 0.34.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first slumped by 39.59% in 2021, then surged by 49.00% in 2022.
  • Jazz Pharmaceuticals' Asset Utilization Ratio (Quarterly) stood at 0.25 in 2021, then spiked by 38.09% to 0.34 in 2022, then fell by 1.61% to 0.34 in 2023, then dropped by 1.18% to 0.34 in 2024, then increased by 10.53% to 0.37 in 2025.
  • Its last three reported values are 0.37 in Q3 2025, 0.36 for Q2 2025, and 0.34 during Q4 2024.